The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Cladaxxa 200 mg/50 mg chewable tablets for cats and dogs



Krka, d.d., Novo mestoVPA10774/071/002

Main Information

Trade NameCladaxxa 200 mg/50 mg chewable tablets for cats and dogs
Active SubstancesAmoxicillin trihydrate
Potassium clavulanate
Dosage FormChewable tablet
Licence HolderKrka, d.d., Novo mesto
Licence NumberVPA10774/071/002

Group Information

ATC CodeQJ01CR02 amoxicillin and enzyme inhibitor
Therapeutic ClassAntibacterial
SpeciesCats
Dogs

Status

Authorised/WithdrawnAuthorised
Licence Issued18/06/2021
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back